STELLA KORETSKY MD NPI 1487841342

NPI Details

Stella Koretsky, MD is a family medicine in San Antonio, TX with 36 years of experience. The provider is family Medicine is the medical specialty which is concerned with the total health care of the individual and the family. It is the specialty in breadth which integrates the biological, clinical, and behavioral sciences. The scope of family medicine is not limited by age, sex, organ system, or disease entity. Stella Koretsky, MD NPI is 1487841342. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

9002 CULEBRA RD
SUITE 105
SAN ANTONIO, TX
ZIP 78251-873
Phone: (210) 802-3777

The NPI 1487841342 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Test for allergy using allergenic extract (HCPCS:95004)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Professional service for preparation and provision of 1 or more antigens (HCPCS:95165)
• Annual alcohol misuse screening, 15 minutes (HCPCS:G0442)
• Annual depression screening, 15 minutes (HCPCS:G0444)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Hemoglobin a1c level (HCPCS:83036)
• Professional service for multiple injections of allergen (HCPCS:95117)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) (HCPCS:87811)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Evaluation of psychological test, first hour (HCPCS:96130)
• Administration of psychological or neuropsychological test, first 30 minutes (HCPCS:96136)
• Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Automated urinalysis test (HCPCS:81003)
• Injection, triamcinolone acetonide, preservative free, 1 mg (HCPCS:J3300)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free (HCPCS:90674)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) (HCPCS:G0506)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Injection of trigger points, 1-2 muscles (HCPCS:20552)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes (HCPCS:G0446)
• Removal of impacted ear wax (HCPCS:69210)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Inhalation treatment for airway obstruction or sputum production (HCPCS:94640)
• Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme (HCPCS:J7620)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• Destruction of skin growth, 1-14 growths (HCPCS:17110)
• Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) (HCPCS:87880)
• Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment (HCPCS:G0402)
• Administration of vaccine (HCPCS:90471)

The enumeration date for this NPI number is 9/25/2007 and was last updated on 3/12/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: